Clin2
NCT05997043Possibly a fitRecruiting

Botulinum toxin for overactive bladder in Parkinson's disease

Parkinson's DiseaseOveractive BladderOnabotulinumtoxin A

Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests if botulinum toxin A injections can help control overactive bladder symptoms in people with Parkinson's disease who haven't gotten enough relief from standard bladder medications. It aims to see if the treatment is safe and effective.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
25 years to 80 years
Study type
Interventional

Who can take part

  • You have Parkinson's disease diagnosed by a specialist.
  • You are between 25 and 80 years old.
  • You have had overactive bladder symptoms for at least 3 months that are not well controlled by bladder medications.
  • You are willing to use a catheter to empty your bladder if needed.
  • You are not currently using a catheter to empty your bladder.
  • You have not had botulinum toxin injections for any bladder problem before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04020510Recruiting· Phase 4
Standard versus fewer bladder Botox injections for overactive bladder

This study compares the usual amount of Botox injected into the bladder versus a smaller amount. It aims to see whether fewer injections can reduce overactive bladder symptoms with fewer side effects, like trouble emptying the bladder.

Bethesda, Maryland
NCT06437899Enrolling by invitation
Numbing methods for Botox in the bladder for overactive bladder

This study compares two ways to numb the bladder before a Botox injection for overactive bladder: local anesthesia (numbing medicine in the bladder) versus sedoanalgesia (medication to relax and reduce pain). The goal is to see which method works better and makes patients more comfortable.

Leoben
NCT07187466Not yet recruiting· Phase 4
Treating urinary symptoms in Parkinson disease

This study tests whether a medication called mirabegron, a behavioral program, or both can improve urinary symptoms (like urgency and leakage) in people with Parkinson's disease. It may help you have better bladder control and daily comfort.

Decatur, Georgia
NCT07379372Not yet recruiting
Telemonitoring after Botox for bladder overactivity

This study tests whether telemonitoring (checking in remotely) can help people who have already had Botox injections for bladder overactivity. The goal is to see if it improves symptoms and quality of life without extra clinic visits.

NCT04754737Recruiting
Testing antibiotic timing before bladder Botox injections

This study looks at whether taking antibiotics shortly before bladder Botox injections affects outcomes for people with overactive bladder. It aims to clarify what to do about antibiotic use before treatment.

Stony Brook, New York
NCT05878951Recruiting· Phase 2/Phase 3
Botox during HoLEP for men with overactive bladder symptoms

This study tests whether adding a Botox shot into the bladder during HoLEP surgery helps men with overactive bladder symptoms like urgency, frequent urination, and accidents. You’d be compared to the standard approach to see if symptoms improve after surgery.

Chicago, Illinois

Hear when a new Parkinson’s disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.